Howard Scher
10Patents
2h-index
22Co-inventors
54Inventor score
Filing activity: Feb 2, 1998 → Dec 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6544952B1 | Synthesis of glycoconjugates of the globo-H epitope and uses thereof | Chemistry; Metallurgy | 24 | Expired |
| US6660741B2 | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor | Human Necessities | 5 | Expired |
| US6972170B1 | Markers for prostate cancer | Chemistry; Metallurgy | 2 | Expired |
| US10113200B2 | Genes associated with dasatinib sensitivity | Chemistry; Metallurgy | 2 | Active |
| US11246946B2 | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis | Human Necessities | 2 | Active |
| US10736972B2 | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis | Human Necessities | 1 | Active |
| US11931425B2 | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis | Human Necessities | 1 | Active |
| US6887887B2 | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor | Human Necessities | 1 | Expired |
| US11660354B2 | Inhibitor-functionalized ultrasmall nanoparticles and methods thereof | Physics | 0 | Active |
| US10030271B2 | Gene expression profile associated with prostate cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.